A Study of Dexanabinol in Combination With Chemotherapy in Patients With Advanced Tumours

NCT02423239 · clinicaltrials.gov ↗

PHASE1

Phase

UNKNOWN

Status

112

Enrollment

INDUSTRY

Sponsor class

Conditions

Hepatocellular Carcinoma
Pancreatic Cancer

Interventions

DRUG: Dexanabinol
DRUG: Sorafenib
DRUG: Nab-paclitaxel
DRUG: Gemcitabine

Sponsor

e-Therapeutics PLC